BAILII is celebrating 24 years of free online access to the law! Would you consider making a contribution?
No donation is too small. If every visitor before 31 December gives just £1, it will have a significant impact on BAILII's ability to continue providing free access to the law.
Thank you very much for your support!
 |
[Home] [Databases] [World Law] [Multidatabase Search] [Help] [Feedback] | |
United Kingdom Statutory Instruments |
||
|
You are here: BAILII >> Databases >> United Kingdom Statutory Instruments >> The Health and Social Care Act 2008 (NHS Blood and Transplant Periodic Review) Regulations 2009 No. 3049 URL: http://www.bailii.org/uk/legis/num_reg/2009/uksi_20093049_en_1.html |
||
[New search] [Help]
Made
16th November 2009
Laid before Parliament
23rd November 2009
Coming into force
21st December 2009
The Secretary of State for Health makes the following Regulations in exercise of the powers conferred by sections 49(1) and 161(3) of the Health and Social Care Act 2008(1).
1. These Regulations may be cited as the Health and Social Care Act 2008 (NHS Blood and Transplant Periodic Review) Regulations 2009 and shall come into force on 21st December 2009.
2. The Commission is required to-�
(a) conduct periodic reviews of the carrying on of the regulated activity prescribed in regulation 3(1)(d) of the Health and Social Care Act 2008 (Registration of Regulated Activities) Regulations 2009(2) (regulated activities carried on by NHS Blood and Transplant in England); and
(b) assess the performance of NHS Blood and Transplant(3) following each such review and publish a report of its assessment.
Signed by authority of the Secretary of State for Health
Mike O´Brien
Minister of State,
Department of Health
16th November 2009
(This note is not part of the Regulations)
These Regulations require the Care Quality Commission to conduct periodic reviews of the carrying on of a regulated activity in England by NHS Blood and Transplant, a Special Health Authority established by S.I. 2005/2529. The regulated activity to be reviewed, set out in regulation 3 of the Health and Social Care Act 2008 (Registration of Regulated Activities) Regulations 2009 (S.I. 2009/660), is the management by NHS Blood and Transplant of-�
(a) the supply of blood, blood components and blood derived products intended for transfusion;
(b) the supply of tissues and tissue derived products intended for transplant, grafting or use in a surgical procedure; and
(c) the matching and allocation of donor organs intended for transplant, and of stem cells and bone marrow intended for transfusion.
Following each such review, the Commission is required to assess the performance of NHS Blood and Transplant and publish a report of its assessment.
A full regulatory impact assessment has not been produced for this instrument as no impact on the private or voluntary sectors is foreseen.
NHS Blood and Transplant was established as a Special Health Authority in October 2005: see S.I. 2005/2529. Back [3]
